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Heme deficiency precipitated by CoCl2 administra-
tion to rats leads to a striking decrease in the inducibil-
ity of CYP2B1/B2 mRNA levels and its transcription by
phenobarbitone (PB), besides decreasing the basal lev-
els. Exogenous hemin administration counteracts the
effects of CoCl2 administration. The binding of nuclear
proteins to labeled positive cis-acting element (269 to
298 nucleotides) in the near 5*-upstream region of the
gene is inhibited by CoCl2 administration to saline or
PB-treated rats, as assessed in gel shift assays. Admin-
istration of exogenous hemin to the animal or addition
in vitro to the extracts is able to overcome the effects of
CoCl2 treatment. The protein mediating this effect has
been purified from CoCl2 administered nuclear extracts
by heparin-agarose, positive element oligonucleotide af-
finity, and heme affinity column chromatography. This
65-kDa protein manifests very little binding to the pos-
itive element, but in the presence of certain other nu-
clear proteins, shows a strong heme-responsive binding.
The purified protein binds heme. It is also able to stim-
ulate transcription of a minigene construct of the
CYP2B1/B2 gene containing 2179 nucleotides of the 5*-
upstream region and the I exon in a cell-free system,
manifesting heme response. It is concluded that the 65-
kDa protein mediates the constitutive requirement of
heme for the transcription of CYP2B1/B2 gene.
The transcriptional regulation of the cytochrome P-450
(CYP) supergene family is of considerable interest. The
CYP1A1 gene of rat liver, induced by the prototype drug
3-methylcholanthrene, has been studied in detail. It involves
interaction of the ligand, 3-methylcholanthrene, with the Ah
receptor, translocation of the receptor to the nucleus, and in-
teraction with specific upstream elements (1, 2). The details
regarding the mechanism of transcriptional activation of the
CYP2B1/B2 gene (2B1 and B2 are 97% homologous and hence
treated as a unit) by the prototype drug, phenobarbitone (PB),1
are beginning to emerge. Studies in this laboratory have led to
the identification of a positive cis-acting element (269 to 298
nt) and a negative cis-acting element (2126 to 2160 nt) in the
near 59-upstream region of the CYP2B1/B2 gene (3–5). The
positive element includes the 17-base pair PB-responsive con-
sensus element, referred to as Barbie Box, identified first by
Fulco and co-workers (6–8) in Bacillus megaterium, rat, mice,
and other organisms of barbiturate inducible cytochrome P-450
and other proteins. There have also been other PB-responsive
sequences identified in the CYP2B1/B2 gene of the rat. Shep-
hard et al. (9) have identified two sequences, located between
2183 to 2199 nt and 231 to 272 nt, to be PB-responsive,
although these do not include the “Barbie” elements. In addi-
tion, Trottier et al. (10) have located a sequence between 22155
and 22318 nt to be PB-responsive and Ramsden et al. (11) have
identified an upstream enhancer as far as 220 kilobases. Stud-
ies in this laboratory have led to the development of a model
which proposes that a ;26-kDa protein interacts with the
positive or negative element based on its phosphorylation sta-
tus. It is proposed that the binding of the ;26-kDa protein with
the positive element in its phosphorylated state and with the
negative element in its dephosphorylated state, within the
PB-responsive minimal promoter in the near 59-upstream re-
gion of the CYP2B1/B2 gene, would determine the inducible
and basal states of the gene, respectively. The inducible state
would involve the interaction of the positive element with the
upstream enhancer elements, mediated through protein-pro-
tein interaction (12).
Earlier studies from this laboratory have also implicated
that heme, the prosthetic group of cytochrome P-450, is a
positive modulator of CYP2B1/B2 gene transcription (13–16).
This conclusion is based on the fact that inhibitors of heme
biosynthesis block induction of CYP2B1/B2 mRNA by PB and
its run-on transcription in isolated nuclei. This inhibition is
counteracted by the administration of exogenous hemin. In the
present study it has been possible to demonstrate that a 65-
kDa nuclear protein mediates the positive modulation of
CYP2B1/B2 gene transcription by heme.
MATERIALS AND METHODS
Treatment of Animals—Rats (75–80 g) were injected with PB (8
mg/100 g, intraperitoneal), CoCl2 (6 mg/100 g, subcutaneously), hemin
(75 mg/100 g, intraperitoneal), or saline in appropriate combinations.
CoCl2 in general was injected 30 min before PB or hemin administra-
tion and the rats killed after 5 h.
Plasmids Used—The plasmid pP450e179 containing 360 nt of the
CYP2B2 gene and covering positions 2179 to 1181 nt (3–5) was used as
a template in transcription reactions. pGEM-3Z vector was used to
generate riboprobes.
Gel Mobility Shift Assay—Nuclei were obtained from the livers of
treated rats using the citric acid homogenization procedure (17). The
nuclei were suspended in a buffer containing 10 mM Tris-HCl (pH 7.5),
50 mM NaCl, 0.5 mM MgCl2, 50 mM sucrose, and 10 mM b-mercaptoeth-
anol. NaCl from a stock of 4 M was added drop by drop to a final
concentration of 0.45 M and the suspension left on ice for 30 min with
intermittent vortexing. The suspension was centrifuged at 12,000 rpm
for 10 min and the supernatant dialyzed against nuclear suspension
buffer.
Nuclear extract (1–3 mg) was used for binding with the body labeled
positive element (59-GAGGAGTGAATAGCCAAAGCAGGAGGCGTG-
39) covering 298 nt to 269 nt of the CYP2B2 gene annealed to a
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complementary primer and extended in presence of [a-32P]dCTP.
Poly(dI-dC) was used as a competitor and samples were analyzed on low
ionic strength 9% polyacrylamide gels as described earlier (4, 5). A stock
solution (fresh) of hemin (1 mM) was prepared in 0.1 N NaOH and then
adjusted to pH 8.0 with acid. Appropriate dilutions were made with 10
mM Tris-HCl buffer (pH 8.0) using this stock for gel shift and other
assays. Approximately 2 ml of hemin solution is usually added to a
reaction mixture of 20 ml.
Quantification of CYP2B1/B2 mRNA—Polysomal RNA was isolated
from magnesium-precipitated rat liver polysomes using phenol-chloro-
form extraction procedure (18). CYP2B1/B2 mRNA was quantified by
RNase protection assay using [a-32P]UTP-labeled I exon riboprobe. The
labeled RNA probe was hybridized to 20 mg of polysomal RNA, digested
with ribonuclease A and T1, and then analyzed on polyacrylamide-urea
gels (8% polyacrylamide) followed by autoradiography (5).
Run-on Transcription—This was carried out by the procedure of
Guertin et al. (19) and has been described (3, 4). Briefly, nuclei were
incubated with 200 mCi of [a-32P]UTP and other components including
human placental RNase inhibitor in a total volume of 200 ml for 30 min
at 25 °C. The labeled transcripts (107 cpm) were hybridized to filters
containing I, VI, and IX exon of the CYP2B2 gene. The riboprobes
corresponding to these exons were prepared using pGEM-3Z vector. The
filters were washed inclusive of RNase treatment and then subjected to
autoradiography.
Transcription in Cell-free Extracts—The nuclear extracts prepared
for gel shift assays were used after 80% (NH4)2SO4 fractionation. The
precipitate was dialyzed against nuclear suspension buffer and used.
The reaction in a total volume of 20 ml contained: DNA template (a
minigene construct containing 2179 nt of the 59-upstream region and
the I exon, pP450e179), 25 mM HEPES-KOH (pH 7.0); 50 mM KCl, 6 mM
MgCl2, 0.6 mM each of ATP, GTP, CTP, and UTP, glycerol (12% in final
concentration), 30 units of RNase inhibitor and transcription extract
(50–100 mg of protein/ml). The transcription extract prepared as de-
scribed was found to be very active and 1–2 mg of protein per 20-ml
reaction volume was found adequate. The reaction mixture was incu-
bated at 30 °C for 45 min. The RNA transcripts were then isolated after
RNase-free DNase and proteinase K treatments followed by phenol/
CHCl3 extraction and ethanol precipitation. The transcripts were quan-
tified by the RNase protection method described earlier.
Purification of Heme Responsive Protein from Nuclear Extracts—
Nuclei were prepared from CoCl2-treated rats and the 0.45 M NaCl
extract was dialyzed and passed through a heparin-agarose column in
buffer containing 50 mM NaCl, 25 mM Tris-HCl (pH 7.4), and 2 mM
EDTA. The column was washed with buffer containing 0.3 M NaCl.
Further elution was carried out with buffer containing 0.4 M NaCl and
then with 0.5 M NaCl. The peak protein fractions were pooled, dialyzed,
and used for gel mobility shift assays. The 0.5 M NaCl eluate was
further purified on oligoaffinity column. This was prepared by ligating
a multimer of the positive element in pUC 19, amplified by polymerase
chain reaction, to CNBr-activated Sepharose 4B (12). The column was
washed with the binding buffer (25 mM HEPES-NaOH (pH 7.6), 12.5
mM MgCl2, 1 mM dithiothreitol, and 20% glycerol) and eluted with
buffer containing 1 M NaCl. This was loaded onto a hemin-agarose
column (in the presence of 1 M NaCl), washed thoroughly, and then
eluted with 2 M guanidine-HCl in 50 mM Tris-HCl (pH 8.0). The eluate
was extensively dialyzed against buffer (10 mM Tris-HCl (pH 7.4), 1 mM
EDTA) with repeated changes. The dialysate was concentrated using
membrane filters.
Binding of 65-kDa Protein with Hemin—The purified protein prep-
aration was analyzed on SDS-PAGE (10% gel) and proteins visualized
using silver stain. To examine the heme binding property of the purified
protein, the preparation was incubated with [59Fe]-hemin (10 mCi/mg,
kind gift from National Institute of Immunology, New Delhi) and then
subjected to SDS-PAGE, with the omission of b-mercaptoethanol and
the boiling step. The gel was then subjected to autoradiography. An-
other approach was to fractionate the protein-hemin complex on a
Sepharose 4B column and identify the radioactivity peaks correspond-
ing to protein bound and free hemin.
UV Cross-linking Analysis—This was basically carried out by pooling
up quadruplicates set up for gel shift assays with the 0.5 M NaCl eluate
from the heparin-agarose column and the labeled positive element. The
mixture was taken in a precooled microtiter plate and irradiated for 15
min on ice with UV light (254 nm, maximum intensity: 7000 uw/cm2) at
a distance of 4 cm from the UV source. The sample was then electro-
phoresed on SDS-PAGE (10% gel) and autoradiographed. In another
approach the gel shift assay mixture (pooled samples) after UV irradi-
ation was analyzed by electrophoresis on a preparative 9% native poly-
acrylamide gel as described earlier. The wet gel was exposed to x-ray
film overnight at 4 °C. Bands (II and III) corresponding to DNA-protein
complexes were excised and once again exposed to UV. The complexes
were then eluted in Tris-EDTA buffer and precipitated with 10% (w/v)
trichloroacetic acid. The pellet was thoroughly washed with 70% etha-
nol, acetone, and ether to remove the acid. The final pellet was analyzed
on SDS-PAGE as described earlier.
RESULTS
Earlier studies from this laboratory have shown that CoCl2
treatment leads to a striking decrease in the heme pool (13–16).
The present study has also made use of this reagent to precip-
itate heme deficiency. Earlier studies on mRNA quantification
and run-on transcription were based on filter hybridization and
measurement of radioactivity. Here these experiments have
been repeated using riboprobes and the sensitive method of
RNase protection assay. The results presented in Fig. 1a indi-
cate that PB treatment leads to a striking increase in
CYP2B1/B2 mRNA as monitored using the exon I riboprobe.
CoCl2 treatment leads to a striking inhibition of PB-mediated
induction of CYP2B1/B2 mRNA. Exogenous hemin administra-
tion leads to a partial but significant counteraction of the
effects of CoCl2. Hemin administration at this concentration
has no significant effects when given to saline or PB-treated
rats. Administration of CoCl2 to uninduced rats decreases even
the basal level of CYP2B1/B2 mRNA and this can be bought
back to the basal level by the administration of exogenous
hemin (Fig. 1b). The results presented in Fig. 2 indicate that a
significant increase in run-on transcription is seen after PB
treatment as monitored using exon I, VI, and IX riboprobes.
CoCl2 treatment inhibits a PB-mediated increase in the tran-
scription of CYP2B1/B2 gene and hemin administration is able
to counteract this effect.
The results presented in Fig. 3 indicate that cell-free tran-
scription of pP450e179, the minigene construct containing
2179 nt of the 59-upstream region and exon I, is significantly
enhanced after PB treatment of the animal. The basal as well
as induced levels of transcription are inhibited by CoCl2 treat-
ment. Hemin administration significantly counteracts the ef-
fects of CoCl2 on PB treatment.
Studies from this laboratory have shown that the positive
element (269 to 298 nt) generates three complexes (I, II, III)
with crude nuclear extract in gel shift assays and PB treatment
of the animal leads to a significant intensification of the com-
plexes (4, 12). It was, therefore, of interest to examine whether
CoCl2 treatment would influence binding of nuclear proteins to
the positive cis-acting element. The results presented in Fig. 4
FIG. 1. Effect of CoCl2 and hemin treatments of the animal on
basal and PB-induced levels of CYP2B1/B2 mRNA in rat liver.
The treatment schedule is given in text. Polysomal RNA was used to
quantify CYP2B1/B2 mRNA by the RNase protection method using
exon I riboprobe. Arrow indicates the position of the protected fragment
of expected size in the autoradiogram. a, effect on induced levels. Lanes
1, control (saline); 2, PB; 3, CoCl2; 4, PB 1 CoCl2; 5, hemin; 6, PB 1
hemin; 7, CoCl2 1 hemin; 8, PB 1 CoCl2 1 hemin; 9, riboprobe. b, effect
on basal levels. Lanes 1, control (saline); 2, CoCl2; 3, hemin; 4, CoCl2 1
hemin. The autoradiograms in a and b were exposed overnight and 7
days, respectively.
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reveal that PB treatment leads to a significant increase in the
intensity of complexes I, II, and III and this increase in pre-
vented by CoCl2 treatment. Interestingly, hemin administra-
tion in vivo restores binding in extracts prepared from CoCl2 as
well as PB 1 CoCl2-treated rats. It does not have a significant
effect, when administered to saline or PB-treated rats. The
results presented in Fig. 5 (a, b, and c) reveal that addition of
hemin in vitro (maximal effect obtained at 1027 M) can also
stimulate binding of nuclear extracts prepared from CoCl2-
treated rats to the positive cis-acting element. At the level of
the crude extract, all three complexes show increased binding
to the positive element in the presence of heme. Again, it does
not have a significant effect when added to extracts from con-
trol (saline) or PB-treated rats. The results presented in Fig. 5
also reveal that the stimulatory effect on binding is specific to
hemin addition in vitro and is not shared by equivalent con-
centrations of protoporphyrin or FeCl3.
The next step was to purify the heme-responsive protein
factor in the nuclear extract. For this purpose, nuclear extracts
prepared from CoCl2-treated rats were fractionated on the
heparin-agarose column. The results presented in Fig. 6 reveal
that hemin addition in vitro specifically stimulates binding of
the 0.5 M NaCl eluate from the column to the positive cis-
element. Complex II shows a striking response and complex III
shows a modest response. The 0.4 M NaCl eluate does not show
a heme response in terms of binding. A UV cross-linking anal-
ysis of the 0.5 M NaCl eluate gives a clear complex in SDS-
PAGE indicating a molecular mass of ;65 kDa after subtract-
ing the molecular mass of the oligonucleotide used (Fig. 7a). UV
cross-linking analysis of complex II as such gives an identical
pattern (data not presented). A similar analysis of complex III
reveals a lower molecular mass protein in the range 23–26 kDa
(Fig. 7b).
On this basis, the 0.5 M NaCl eluate was loaded onto a
positive element affinity column and the bound proteins were
eluted with 1 M NaCl. This was loaded onto the heme affinity
column and the bound proteins were eluted with 2 M guanidine
HCl. The eluate was extensively dialyzed and SDS-PAGE anal-
ysis reveals a single protein band of 65 kDa (Fig. 8). Next,
binding studies were carried out with the purified protein and
labeled positive element. The preparation shows hardly any
binding to the positive element, but in the presence of small
amounts of crude nuclear extract (100 ng of protein from un-
induced rats), which by itself does not generate easily detecta-
ble complexes, manifests a striking heme-responsive increase
in the intensity of complex II. Both the purified protein and
hemin are required to elicit maximal response. Complex III
shows a modest response (Fig. 9, a and b). Qualitatively similar
FIG. 4. Effect of CoCl2 and hemin treatments of the animal on
the binding of nuclear proteins with the labeled positive ele-
ment. The preparation of crude nuclear extract and gel shift assay
conditions are described in text. I, II, and III refer to the three com-
plexes obtained with 1 mg of protein under the experimental conditions
used. Gel shift assays were carried out in a total volume of 20 ml. The
treatments given are: lanes 1, control (saline); 2, CoCl2; 3, PB; 4, PB 1
CoCl2; 5, hemin; 6, PB 1 hemin; 7, CoCl2 1 hemin; 8, PB 1 CoCl2 1
hemin; 9, free probe. Addition of solvent alone used to solubilize and
dilute hemin at appropriate concentrations has no effect on the gel shift
pattern obtained.
FIG. 5. Effects of hemin, protoporphyrin, and FeCl3 in vitro on
the binding of the nuclear proteins with the labeled positive
element. The optimal hemin concentration was arrived at after testing
the effect at different concentrations. a, nuclear extracts prepared from
CoCl2-treated rats were used. To clearly visualize the complexes, 2.5 mg
of protein was used. Lanes 1, no addition; 2, hemin (1027 M); 3, proto-
porphyrin (1027 M); FeCl3 (10
27 M). b and c, nuclear extracts from
control animals (saline) and PB-treated animals, respectively, were
used at 1 mg of protein level. Lanes 1, no addition; 2, hemin (1027 M).
FIG. 2. Effect of CoCl2 and hemin treatments of the animal on
the activation of run-on transcription of CYP2B1B2 gene by
phenobarbitone in rat liver. The experimental details are described
in text. The riboprobes used are for exon I (201 nt), exon VI (300 nt),
exon IX (417 nt), and pBR322. The exon I probe includes 20 nt of the
polylinker region. Nuclei were prepared from animals given the follow-
ing treatments: Lanes 1, control (saline); 2, PB; 3, PB 1 CoCl2; 4, PB 1
CoCl2 1 hemin.
FIG. 3. Effect of CoCl2 and hemin treatments of the animal on
cell-free transcription of pP450e179 DNA. The experimental de-
tails are given in text. Arrow indicates the position of the protected
fragment of expected size in the autoradiogram. Transcription extracts
were prepared from animals given the following treatments: Lanes 1,
control (saline); 2, PB; 3, CoCl2; 4, PB 1 CoCl2; 5, PB 1 CoCl2 1 hemin.
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results are obtained when the purified protein is used with
nuclear extracts prepared from CoCl2-treated rats (data not
presented). Addition of BSA to crude extract does not elicit a
similar response, indicating that the heme-dependent increase
in binding to the positive element is specific to the 65-kDa
protein (Fig. 9c). It is interesting to note that complexes II and
III but not complex I are manifest with 0.5 M NaCl-heparin
eluate of the CoCl2-treated extract. Once again, complex II
shows maximum response with hemin addition, although com-
plex III also manifests some response. In addition, with the
heparin column eluate maximum response is seen with 1029 M
hemin, whereas the optimal hemin concentration for crude
extract as already indicated is 1027 M. The purified ;65-kDa
protein also shows a maximum response around 1028 to 1029 M
hemin concentration for binding to the positive cis-acting ele-
ment. This depends on the amount and source of crude nuclear
extract added, uninduced or CoCl2-treated, along with the 65-
kDa protein to elicit the response. It is found that higher
concentrations of hemin (1026 to 1025 M) are inhibitory. Thus,
a higher concentration of hemin (1027 M) is tolerated at the
level of crude extract, since there are other proteins that may
be able to compete for binding. As the protein is purified the
competing proteins are removed and therefore the optimum
hemin concentration to facilitate maximum binding gets lower.
It was then of interest to examine whether the heme-affinity
column purified protein actually binds heme. For this purpose,
the preparation was incubated with [59Fe]-labeled hemin and
then analyzed on SDS-PAGE, omitting the boiling step and
addition of b-mercaptoethanol. A radioactive complex with a
mobility of ;65 kDa is clearly seen on the autoradiogram (Fig.
10) indicating that the protein binds heme. The protein-[59Fe]-
labeled hemin complex was also fractionated on a Sepharose 4B
column, which indicates that the heme-binding proteins mi-
grates in the region of a BSA standard of mass of 65 kDa
(Fig. 10b).
Finally, the purified preparation was examined for its poten-
tial to manifest heme-responsive stimulation of the transcrip-
tion of pP450e179 DNA in cell-free extracts. For this purpose,
the crude transcription extract was prepared from nuclei of
CoCl2-treated rats. The results presented in Fig. 11 (a and b) on
the basis of laser densitometric analysis reveal that addition of
hemin (1028 M) or the purified protein (2 mg) to the transcrip-
tion extract shows about 3- and 4–5-fold stimulation of tran-
scription, respectively. The addition of the two together shows
nearly 12-fold stimulation (Fig. 11a). There is also a significant
graded response to the addition of increasing concentrations of
the purified protein in the presence of hemin (Fig. 11b).
DISCUSSION
The present study clearly reveals that CoCl2 treatment leads
to a striking inhibition of CYP2B/B2 gene transcription that is
overcome by the administration of low concentrations of hemin.
The basal (uninduced) as well as PB-induced CYP2B1/B2
mRNA levels are also depressed by CoCl2 treatment and coun-
teracted by hemin administration (Fig. 1). Run-on and cell-free
transcription studies indicate that CoCl2 inhibits the PB-me-
diated increase in transcription and this is counteracted by the
administration of exogenous hemin (Figs. 2 and 3). Cell-free
transcription studies have indicated that the heme response
element is within the 179 nt of the immediate 59-upstream
region of the CYP2B1/B2 gene.
Gel shift analysis with the positive element (269 to 298 nt)
correlates well with the inhibitory and counteracting effects of
CoCl2 and hemin, respectively, on CYP2B1/B2 mRNA levels
and transcription status. As already reported (4, 12) crude
FIG. 6. Effect of hemin in vitro on the binding of nuclear pro-
teins fractionated on the heparin-agarose column with the la-
beled positive element. The nuclear extract from CoCl2-treated rat
livers was fractionated on heparin-agarose column. The experimental
details are given in the text. Lanes 1–4 and 5–8 refer to complexes
obtained with 0.4 and 0.5 M NaCl eluates from the heparin-agarose
column, respectively. Lanes 1 and 5, no addition; 2 and 6, hemin (1027
M); 3 and 7, hemin (1028 M); 4 and 8, hemin (1029 M).
FIG. 7. UV cross-linking analysis of the DNA- protein complex
obtained with 0.5 M NaCl eluate of the heparin-agarose column
and labeled positive element. The experimental details are given in
the text. a, the 0.5 M eluate was used to bind with labeled positive
element and the mixture exposed to UV and then analyzed on SDS-
PAGE (10% gel). Lanes 1 and 2 are duplicates. b, complex III was
specifically eluted after gel shift analysis and UV irradiation. The
eluate was then analyzed on SDS-PAGE (10% gel). Lanes 1 and 2,
complex III from two different experiments. Preparation 1 had five
times more radioactivity than preparation 2; 3, free DNA. The molec-
ular weight markers are indicated.
FIG. 8. SDS-PAGE analysis of the protein purified from nu-
clear extract of CoCl2-treated rats. The various purification steps
are given in text. The final preparation obtained after hemin-affinity
column fractionation was analyzed on SDS-PAGE (10% gel) and stained
with silver nitrate. Lanes 1, molecular weight markers; 2, purified
protein: ov, ovalbumin.
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nuclear extract gives three complexes (I, II, and III) with the
positive element. The present study reveals that CoCl2 treat-
ment leads to a suppression of formation of all the three com-
plexes both in the presence and absence of PB treatment. At
the level of the crude nuclear extract isolated from CoCl2-
treated rats, all the three complexes intensify on hemin addi-
tion (Fig. 4). The effect is specific for hemin, since protoporphy-
rin or iron fail to elicit a similar effect (Fig. 5). After
fractionation on the heparin-agarose column, with the 0.5 M
NaCl eluate, complex II shows a striking increase in intensity
to hemin addition and complex III shows a modest increase in
intensity (Fig. 6). UV cross-linking analysis indicates that com-
plex III consists of the ;26-kDa protein (Fig. 7). This is in
agreement with the results reported from this laboratory (12),
where the ;26-kDa protein purified from the 0.4 M NaCl eluate
of the heparin-agarose column on the positive element oligonu-
cleotide affinity column, has been shown to give rise to complex
III with the positive element in gel shift analysis. The complex
is faint, but in the presence of low amounts of crude nuclear
extract or on concentrations of the purified fraction all the
three complexes (I, II, and III) are manifest. The present study
also reveals that complex II consists of the ;65-kDa protein,
although traces of lower molecular weight proteins are also
seen on UV cross-linking analysis. This is corraborated by the
findings that the 0.5 M NaCl eluate of the CoCl2-treated nuclear
extracts from the heparin-agarose column gives a striking re-
sponse to hemin addition in terms of generating complex II
with the positive element (Fig. 6) and that a ;65-kDa heme-
FIG. 9. Binding of 65-kDa protein
with labeled positive element. The
conditions for gel shift assay are de-
scribed in text. a, effect of 65-kDa protein
on binding. Lanes 1, crude extract (100 ng
of protein); 2, purified protein (;2–3 ng);
3, crude extract 1 purified protein; 4–6,
same as 3 plus 1027, 1028, or 1029 M he-
min added in vitro, respectively. b, repeat
experiment in a. Lanes 1, crude extract
(100 ng of protein); 2, purified protein
(2–3 ng); 3, crude extract1 1029 M hemin;
4, crude extract 1 purified protein; 5,
crude extract 1 purified protein 1 hemin
1029 M. c, effect of BSA on binding. Lanes
1, crude extract (100 ng of protein); 2,
crude extract 1 BSA (1 mg); 3 BSA (1 mg);
4–6, same as 3 plus 1027, 1028, or 1029 M
hemin, respectively.
FIG. 10. Binding of the 650-kDa pro-
tein to 59Fe-labeled hemin. The puri-
fied protein (;50–60 ng) was incubated
with [59Fe] labeled hemin (10 mCi/mg) as
described in text. a, the complex was an-
alyzed on SDS-PAGE (10% gel) omitting
b-mercaptoethanol and the boiling step.
Arrow indicates mobility of bovine serum
albumin on the autoradiogram. b, the
complex was fractionated on a Sepharose
4B column (22 3 1.7 cm) and 1-ml frac-
tions were collected for measurement of
radioactivity. The column was also sepa-
rately calibrated with BSA and free [59Fe]
labeled hemin.
FIG. 11. Effect of hemin and 65-kDa protein addition on the
transcription of pP450e179 DNA in cell free extracts. Transcrip-
tion extracts were prepared from CoCl2-treated rat liver nuclei as
described in text. The transcripts were analyzed by RNase protection
assay using exon I riboprobe. Treatments represent additions to the
transcription mixture. Arrow indicates the position of the protected
fragment of expected size in the autoradiogram. Lanes 1, complete
reaction with extract (no addition of hemin or purified protein); 2, probe
alone. 3, 1028 M hemin; 4, ;2 ng of 65-kDa protein; 5, 1028 M hemin 1
;2 ng of 65-kDa protein. b, duplicate experiment. Lanes 1, 2 ng of
65-kDa protein; 2–4, 1028 M hemin 1 2, 4, or 6 ng of 65-kDa protein,
respectively. Arrows indicate the position of the protected fragment of
expected size.
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binding protein can be purified from this fraction using oligo-
nucleotide and heme affinity columns (Figs. 8 and 10). As
already indicated, the 0.5 M NaCl eluate from the heparin
column also manifests heme-dependent generation of complex
III, although complex II is dominant. It may be pointed that
traces of low molecular mass proteins can be seen in the puri-
fied 65-kDa preparation. Once again binding of the purified
;65-kDa protein to the positive element is very poor and sig-
nificant binding in the presence of hemin to the element is seen
when small amounts of crude nuclear extract are added (Fig.
9). Thus, protein-protein interaction is essential for the binding
of ;26- and ;65-kDa proteins to the positive element. UV
cross-linking analysis of complexes II and III perhaps reveal
only the proteins that make primary contact with positive
elements and the other proteins involved in protein-protein
interaction need to be identified.
In a recent study, it has been shown in this laboratory (12)
that the ;26-kDa protein shows greater affinity to the positive
(269 to 298 nt) and negative (2126 to 2166 nt) elements in its
phosphorylated and dephosphorylated states, respectively, pro-
viding a basis for a differential interaction of the protein with
the two elements in induced and uninduced states. While, the
role of heme in the interaction of proteins to negative element
is yet to be investigated, it is clear that interaction of the
;65-kDa protein with the positive element is heme dependent.
Since, heme depletion leads to a decrease in basal as well as
PB-induced transcription of the CYP2B1/B2 gene that is coun-
teracted by the exogenous administration of hemin, it can be
concluded that heme requirement is constitutive.
Earlier studies from this laboratory (3) have shown by South-
western blot analysis that a ;94-kDa protein shows up when
the entire 179 nt of the 59-upstream region of the CYP2B1/B2
gene is used as a probe. PB treatment significantly enhances
the intensity of this complex and this increase is blocked by
CoCl2 treatment of the animal. Thus, there are at least three
proteins with molecular mass values of ;94, ;65, and ;26
kDa, whose interaction with the positive element and its neigh-
borhood is influenced by the availability of heme and this in
turn may influence the interaction of this protein assembly
with the far upstream enhancer proposed by Ramsden et al.
(11) as well as the initiation complex, leading to productive
transcription of the CYP2B1/B2 gene. The ;65-kDa protein is
perhaps the dominant protein that interacts with heme and
facilitates interaction with other proteins and positive element.
It needs to be studied whether heme has a direct role in the
interaction of the ;26- and ;94-kDa proteins with cis-acting
DNA elements. Fig. 12 depicts the model envisaged for the
heme-dependent interaction of the proteins with the positive
element. The ;26-kDa protein has already been shown to
stimulate transcription of the minigene construct containing
the positive element (pP450e179) in cell-free extracts (12). In
the present study, the ;65-kDa protein has been shown to
stimulate transcription of the pP450e179 DNA in cell-free ex-
tracts prepared from CoCl2-treated rat liver nuclei in a heme
dependent fashion. It, therefore, appears likely that the two
proteins are positive regulators of the gene with binding sites
on the positive element, although the possible interaction be-
tween the two needs to be studied.
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FIG. 12. A model depicting the role of heme in the interaction
of proteins with the positive element. PE, positive element; NE,
negative element; E, enhancer-binding protein; EN, enhancer; IC, ini-
tiation complex.
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